Peter K Lindenauer1,2,3, Mihaela S Stefan1,2, Penelope S Pekow1,4, Kathleen M Mazor5, Aruna Priya1,4, Kerry A Spitzer1, Tara C Lagu1,2, Quinn R Pack1,2,6, Victor M Pinto-Plata2,7, Richard ZuWallack8. 1. Institute for Healthcare Delivery and Population Science, University of Massachusetts Medical School-Baystate, Springfield. 2. Department of Medicine, University of Massachusetts Medical School-Baystate, Springfield. 3. Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester. 4. University of Massachusetts School of Public Health and Health Sciences, Amherst. 5. The Meyers Primary Care Institute, University of Massachusetts Medical School, Worcester. 6. Division of Cardiovascular Medicine, University of Massachusetts Medical School-Baystate, Springfield. 7. Divsion of Pulmonary and Critical Care Medicine, University of Massachusetts Medical School-Baystate, Springfield. 8. Pulmonary and Critical Care Division, Saint Francis Hospital and Medical Center, Hartford, Connecticut.
Abstract
Importance: Meta-analyses have suggested that initiating pulmonary rehabilitation after an exacerbation of chronic obstructive pulmonary disease (COPD) was associated with improved survival, although the number of patients studied was small and heterogeneity was high. Current guidelines recommend that patients enroll in pulmonary rehabilitation after hospital discharge. Objective: To determine the association between the initiation of pulmonary rehabilitation within 90 days of hospital discharge and 1-year survival. Design, Setting, and Patients: This retrospective, inception cohort study used claims data from fee-for-service Medicare beneficiaries hospitalized for COPD in 2014, at 4446 acute care hospitals in the US. The final date of follow-up was December 31, 2015. Exposures: Initiation of pulmonary rehabilitation within 90 days of hospital discharge. Main Outcomes and Measures: The primary outcome was all-cause mortality at 1 year. Time from discharge to death was modeled using Cox regression with time-varying exposure to pulmonary rehabilitation, adjusting for mortality and for unbalanced characteristics and propensity to initiate pulmonary rehabilitation. Additional analyses evaluated the association between timing of pulmonary rehabilitation and mortality and between number of sessions completed and mortality. Results: Of 197 376 patients (mean age, 76.9 years; 115 690 [58.6%] women), 2721 (1.5%) initiated pulmonary rehabilitation within 90 days of discharge. A total of 38 302 (19.4%) died within 1 year of discharge, including 7.3% of patients who initiated pulmonary rehabilitation within 90 days and 19.6% of patients who initiated pulmonary rehabilitation after 90 days or not at all. Initiation within 90 days was significantly associated with lower risk of death over 1 year (absolute risk difference [ARD], -6.7% [95% CI, -7.9% to -5.6%]; hazard ratio [HR], 0.63 [95% CI, 0.57 to 0.69]; P < .001). Initiation of pulmonary rehabilitation was significantly associated with lower mortality across start dates ranging from 30 days or less (ARD, -4.6% [95% CI, -5.9% to -3.2%]; HR, 0.74 [95% CI, 0.67 to 0.82]; P < .001) to 61 to 90 days after discharge (ARD, -11.1% [95% CI, -13.2% to -8.4%]; HR, 0.40 [95% CI, 0.30 to 0.54]; P < .001). Every 3 additional sessions was significantly associated with lower risk of death (HR, 0.91 [95% CI, 0.85 to 0.98]; P = .01). Conclusions and Relevance: Among fee-for-service Medicare beneficiaries hospitalized for COPD, initiation of pulmonary rehabilitation within 3 months of discharge was significantly associated with lower risk of mortality at 1 year. These findings support current guideline recommendations for pulmonary rehabilitation after hospitalization for COPD, although the potential for residual confounding exists and further research is needed.
Importance: Meta-analyses have suggested that initiating pulmonary rehabilitation after an exacerbation of chronic obstructive pulmonary disease (COPD) was associated with improved survival, although the number of patients studied was small and heterogeneity was high. Current guidelines recommend that patients enroll in pulmonary rehabilitation after hospital discharge. Objective: To determine the association between the initiation of pulmonary rehabilitation within 90 days of hospital discharge and 1-year survival. Design, Setting, and Patients: This retrospective, inception cohort study used claims data from fee-for-service Medicare beneficiaries hospitalized for COPD in 2014, at 4446 acute care hospitals in the US. The final date of follow-up was December 31, 2015. Exposures: Initiation of pulmonary rehabilitation within 90 days of hospital discharge. Main Outcomes and Measures: The primary outcome was all-cause mortality at 1 year. Time from discharge to death was modeled using Cox regression with time-varying exposure to pulmonary rehabilitation, adjusting for mortality and for unbalanced characteristics and propensity to initiate pulmonary rehabilitation. Additional analyses evaluated the association between timing of pulmonary rehabilitation and mortality and between number of sessions completed and mortality. Results: Of 197 376 patients (mean age, 76.9 years; 115 690 [58.6%] women), 2721 (1.5%) initiated pulmonary rehabilitation within 90 days of discharge. A total of 38 302 (19.4%) died within 1 year of discharge, including 7.3% of patients who initiated pulmonary rehabilitation within 90 days and 19.6% of patients who initiated pulmonary rehabilitation after 90 days or not at all. Initiation within 90 days was significantly associated with lower risk of death over 1 year (absolute risk difference [ARD], -6.7% [95% CI, -7.9% to -5.6%]; hazard ratio [HR], 0.63 [95% CI, 0.57 to 0.69]; P < .001). Initiation of pulmonary rehabilitation was significantly associated with lower mortality across start dates ranging from 30 days or less (ARD, -4.6% [95% CI, -5.9% to -3.2%]; HR, 0.74 [95% CI, 0.67 to 0.82]; P < .001) to 61 to 90 days after discharge (ARD, -11.1% [95% CI, -13.2% to -8.4%]; HR, 0.40 [95% CI, 0.30 to 0.54]; P < .001). Every 3 additional sessions was significantly associated with lower risk of death (HR, 0.91 [95% CI, 0.85 to 0.98]; P = .01). Conclusions and Relevance: Among fee-for-service Medicare beneficiaries hospitalized for COPD, initiation of pulmonary rehabilitation within 3 months of discharge was significantly associated with lower risk of mortality at 1 year. These findings support current guideline recommendations for pulmonary rehabilitation after hospitalization for COPD, although the potential for residual confounding exists and further research is needed.
Authors: Tobias Kurth; Alexander M Walker; Robert J Glynn; K Arnold Chan; J Michael Gaziano; Klaus Berger; James M Robins Journal: Am J Epidemiol Date: 2005-12-21 Impact factor: 4.897
Authors: Jadwiga A Wedzicha; Marc Miravitlles; John R Hurst; Peter M A Calverley; Richard K Albert; Antonio Anzueto; Gerard J Criner; Alberto Papi; Klaus F Rabe; David Rigau; Pawel Sliwinski; Thomy Tonia; Jørgen Vestbo; Kevin C Wilson; Jerry A Krishnan Journal: Eur Respir J Date: 2017-03-15 Impact factor: 16.671
Authors: Linda Nici; Jonathan Raskin; Carolyn L Rochester; Jean C Bourbeau; Brian W Carlin; Richard Casaburi; Bartolome R Celli; Claudia Cote; Rebecca H Crouch; Luis F Diez-Morales; Claudio F Donner; Bonnie F Fahy; Chris Garvey; Roger Goldstein; Alison Lane-Reticker; Suzanne C Lareau; Barry Make; François Maltais; James McCormick; Michael D L Morgan; Andrew Ries; Thierry Troosters; Richard ZuWallack Journal: J Cardiopulm Rehabil Prev Date: 2009 May-Jun Impact factor: 2.081
Authors: Peter K Lindenauer; Kumar Dharmarajan; Li Qin; Zhenqiu Lin; Andrea S Gershon; Harlan M Krumholz Journal: Am J Respir Crit Care Med Date: 2018-04-15 Impact factor: 30.528
Authors: Stefanie Elizabeth Mason; Rafael Moreta-Martinez; Wassim W Labaki; Matthew Strand; David Baraghoshi; Elizabeth A Regan; Jessica Bon; Ruben San Jose Estepar; Richard Casaburi; Merry-Lynn N McDonald; Harry Rossiter; Barry J Make; Mark T Dransfield; MeiLan K Han; Kendra A Young; Greg Kinney; John E Hokanson; Raul San Jose Estepar; George R Washko Journal: Thorax Date: 2021-02-11 Impact factor: 9.139
Authors: Amaya Jimeno-Almazán; Jesús G Pallarés; Ángel Buendía-Romero; Alejandro Martínez-Cava; Francisco Franco-López; Bernardino J Sánchez-Alcaraz Martínez; Enrique Bernal-Morel; Javier Courel-Ibáñez Journal: Int J Environ Res Public Health Date: 2021-05-17 Impact factor: 3.390